[1] Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2015, 31(11): 1752-1769. [2] Shen T,Liu YX, Shang J, et al.Incidence and etiology of drug-induced liver injury in mainland China[J]. Gastroenterology, 2019, 156(8): 2230-2241. [3] National Center for ADR Monitoring, China. Guidelines for the use of adverse drug reaction terms(药品不良反应术语使用指南)[S]. 2016: 15-16. [4] Chen XQ, Jin YY, Tang G. New Pharmacology(新编药物学)[M]. Beijing: People's Medical Publishing House, 2011. [5] Björnsson ES, Bergmann OM, Björnsson HK, et al.Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland[J]. Gastroenterology, 2013, 144(7): 1419-1425. [6] Bjornsson ES.Epidemiology and risk factors for idiosyncratic drug-induced liver injury[J]. Semin Liver Dis, 2014, 34(2): 115-122. [7] Yang W, Wang Q.Analysis of the clinical characteristics and prognosis of 371 cases of drug-induced liver injury in our hospital[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(5): 293-296. [8] Li LH, Wang LL.Drug history, risk factors and clinical characte-ristics of 100 cases of drug-induced liver injury[J]. Chinese Hepatology(肝脏), 2017, 22(10): 922-924. [9] Nguyen GC, Justina S, Thuluvath PJ.Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: a nationwide analysis[J]. Hepatology, 2010, 48(4): 1336-1341. [10] Jia WP, Guo DH, Tian XY, et al.Analysis of 1110 cases of drug-induced liver injury in 79 hospitals[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017, 14(8): 481-485. [11] Yang SL.Clinical analysis of diabetic liver injury[J]. Contemporary Medicine(当代医学), 2012, 18(20): 95. [12] Hou FQ, Zeng Z, Wang GQ.Hospital admissions for drug-induced liver injury: clinical features, therapy, and outcomes[J]. Cell Biochem Biophys, 2012, 64(2): 77-83. [13] Wu YH, Wu QH.Literature analysis of 1 949 cases liver injury induced by anti-TB drugs[J]. Northwest Pharmaceutical Journal(西北药学杂志), 2015, 30(6): 750-753. [14] Fan H, Wang GH, Li JC,et al.Treatment compliance and influencing factors in pulmonary tuberculosis patients accompanied by drug-induced liver injury[J]. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease(实用心脑肺血管病杂志), 2019, 27(3): 50-53. [15] Bender S, Grohmann R, Engel RR, et al.Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics[J]. Pharmacopsychiatry, 2004, 37(1): 46-53. [16] Wei L, Zhao CJ.Clinical pharmacists participating in pharmac-eutical care for patients with parenteral nutrition-associated liver damage[J]. China Pharmacy(中国药房), 2017, 28(17): 2429-2432. [17] Jiao YT, Gao J, Ren B, et al.Hepatotoxicity and nephrotoxicity of chinese herbal medicine and their countermeasures[J]. World Chinese Medicine(世界中医药), 2014, 9(1): 124-127. [18] Zhang SN, Li XZ, Lu F,et al.New direction in chinese materia medica toxicity study: discovery of potential toxicity in“non-toxic”drugs[J]. World Science and Technology-Modernization of Traditional Chinese(世界科学技术-中医药现代化), 2015, 17(3): 627-632. [19] Branch of Chinese Patent Medicine, China Association of Chinese Medicine; Branch of Hepatobiliary Diseases, China Association of Chinese Medicine; Professional Committee of Clinical Chinese Pharmacy, Chinese Pharmaceutical Association; et al. Guidelines for safe use of polygoni multiflori radixl[J]. Journal of Clinical Hepatology(临床肝胆病杂志), 2019, 35(12): 2687-2693. |